Balaji Gandhi Sells 948 Shares of Phreesia, Inc. (NYSE:PHR) Stock

Phreesia, Inc. (NYSE:PHR) CFO Balaji Gandhi sold 948 shares of the stock in a transaction that occurred on Monday, April 15th. The shares were sold at an average price of $22.86, for a total value of $21,671.28. Following the transaction, the chief financial officer now owns 97,230 shares of the company’s stock, valued at $2,222,677.80. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink.

Balaji Gandhi also recently made the following trade(s):

• On Monday, April 8th, Balaji Gandhi sold 7,778 shares of Phreesia stock. The shares were sold at an average price of $22.62, for a total value of $175,938.36.
• On Monday, March 25th, Balaji Gandhi sold 3,504 shares of Phreesia stock. The shares were sold at an average price of $23.21, for a total value of $81,327.84.

Phreesia Price Performance

Shares of NYSE PHR opened at $22.62 on Friday. Phreesia, Inc. has a 1-year low of $12.05 and a 1-year high of $34.98. The company has a quick ratio of 1.78, a current ratio of 1.78 and a debt-to-equity ratio of 0.02. The business’s fifty day moving average price is $24.40 and its two-hundred day moving average price is $21.26.

Phreesia (NYSE:PHR) last issued its quarterly earnings results on Thursday, March 14th. The company reported ($0.56) EPS for the quarter, beating analysts’ consensus estimates of ($0.58) by $0.02. The company had revenue of $95.00 million for the quarter, compared to analyst estimates of $93.52 million. Phreesia had a negative return on equity of 53.33% and a negative net margin of 38.42%. The company’s quarterly revenue was up 24.0% compared to the same quarter last year. During the same period last year, the company earned ($0.72) earnings per share. On average, analysts anticipate that Phreesia, Inc. will post -1.48 EPS for the current fiscal year.

Institutional Inflows and Outflows

A number of large investors have recently modified their holdings of PHR. Brown Advisory Inc. increased its holdings in shares of Phreesia by 22.2% during the fourth quarter. Brown Advisory Inc. now owns 3,950,356 shares of the company’s stock valued at $91,451,000 after purchasing an additional 716,374 shares during the period. FMR LLC increased its holdings in shares of Phreesia by 8.6% during the third quarter. FMR LLC now owns 7,856,551 shares of the company’s stock valued at $146,760,000 after purchasing an additional 624,456 shares during the period. Rock Springs Capital Management LP increased its holdings in shares of Phreesia by 36.1% during the third quarter. Rock Springs Capital Management LP now owns 1,776,391 shares of the company’s stock valued at $33,183,000 after purchasing an additional 471,391 shares during the period. Norges Bank acquired a new position in shares of Phreesia during the fourth quarter valued at $8,199,000. Finally, BlackRock Inc. increased its holdings in shares of Phreesia by 5.8% during the first quarter. BlackRock Inc. now owns 6,359,641 shares of the company’s stock valued at $167,640,000 after purchasing an additional 349,301 shares during the period. 92.10% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several research firms have recently commented on PHR. Truist Financial began coverage on Phreesia in a research note on Monday, February 26th. They set a “buy” rating and a $35.00 target price for the company. Barclays began coverage on Phreesia in a research report on Wednesday, January 3rd. They set an “overweight” rating and a $29.00 price target on the stock. Needham & Company LLC reissued a “buy” rating and set a $29.00 price target on shares of Phreesia in a research report on Friday, March 15th. Robert W. Baird upped their price target on Phreesia from $30.00 to $31.00 and gave the company an “outperform” rating in a research report on Monday, March 18th. Finally, Royal Bank of Canada reissued a “sector perform” rating and set a $23.00 price target on shares of Phreesia in a research report on Thursday, March 21st. Two analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company’s stock. Based on data from MarketBeat, Phreesia has an average rating of “Moderate Buy” and a consensus price target of $31.62.

Phreesia Company Profile

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.